SJM Q1 2026 Earnings EPS Exceeds Consensus Shares Move Higher OVID Q1 2026 Earnings Narrower Loss and No Revenue Mark a Quiet Quarter for the Biotech CGTX Q1 2026 Earnings Cognition Therapeutics Reports NarrowerThanExpected Loss No Revenue Yet MeiraGTx Q1 2026 Earnings Wider Loss Surprises Analysts Stock Rises on Pipeline Momentum FiscalNote Q1 2026 Earnings EPS Surprise Beats Estimates Despite Stock Decline PROK Q1 2026 Earnings Narrow Loss Beat Highlights Steady Progress in Cell Therapy Pipeline